Literature DB >> 12963044

Parkin suppresses wild-type alpha-synuclein-induced toxicity in SHSY-5Y cells.

Yemisi Oluwatosin-Chigbu1, Alan Robbins, Clay W Scott, Jeffrey L Arriza, John D Reid, John R Zysk.   

Abstract

Current hypotheses concerning the mechanism of neuronal cell death in Parkinson's disease (PD) and related synucleopathies propose a functional interaction between parkin and alpha-synuclein (alphaS). Recently parkin was shown to suppress mutant alphaS-induced toxicity in primary neurons, providing a basis for an association between these proteins and neuronal loss [Neuron 36 (2000) 1007-1019]. We have asked if a similar association could be made between wild-type (wt) alphaS and parkin. We examined inducible over-expression of alphaS in SHSY-5Y cells through adenoviral infection under conditions which produce cellular toxicity through a reduction in ATP levels. We demonstrate that parkin suppresses toxicity induced by mutant (A53T) and wt alphaS. Parkin over-expression was also associated with the appearance of higher molecular weight alphaS-immunoreactive bands by Western blot analysis. These data, consistent with a protective role for parkin, extend previous findings to include a functional association between parkin and the wt form of alphaS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963044     DOI: 10.1016/j.bbrc.2003.08.059

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.

Authors:  Zhihua Liu; Robin K Meray; Tom N Grammatopoulos; Ross A Fredenburg; Mark R Cookson; Yichin Liu; Todd Logan; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

Review 2.  Gene therapy targeting mitochondrial pathway in Parkinson's disease.

Authors:  Chi-Jing Choong; Hideki Mochizuki
Journal:  J Neural Transm (Vienna)       Date:  2016-09-16       Impact factor: 3.575

Review 3.  Amphetamine toxicities: classical and emerging mechanisms.

Authors:  Bryan K Yamamoto; Anna Moszczynska; Gary A Gudelsky
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

4.  Ginsenoside rb1 and rg3 attenuate glucocorticoid-induced neurotoxicity.

Authors:  Sung-Ok Kim; Jung-Man You; Su-Jin Yun; Min-Sook Son; Kyong Nyon Nam; Joung-Woo Hong; Sun Yeou Kim; Sang Yoon Choi; Eunjoo H Lee
Journal:  Cell Mol Neurobiol       Date:  2010-03-25       Impact factor: 5.046

5.  Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.

Authors:  Alexander J Whitworth; Dorothy A Theodore; Jessica C Greene; Helen Benes; Paul D Wes; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

6.  Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.

Authors:  Christophe Lo Bianco; Bernard L Schneider; Matthias Bauer; Ali Sajadi; Alexis Brice; Takeshi Iwatsubo; Patrick Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

7.  Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.

Authors:  Bin Liu; Roberta Traini; Bryan Killinger; Bernard Schneider; Anna Moszczynska
Journal:  Exp Neurol       Date:  2013-01-09       Impact factor: 5.330

8.  Transcriptional dysregulation in a transgenic model of Parkinson disease.

Authors:  Talene A Yacoubian; Ippolita Cantuti-Castelvetri; Bérengère Bouzou; Georgios Asteris; Pamela J McLean; Bradley T Hyman; David G Standaert
Journal:  Neurobiol Dis       Date:  2007-11-28       Impact factor: 5.996

9.  Parkin counteracts symptoms in a Drosophila model of Parkinson's disease.

Authors:  Annika F M Haywood; Brian E Staveley
Journal:  BMC Neurosci       Date:  2004-04-16       Impact factor: 3.288

10.  Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity.

Authors:  Anna Moszczynska; Jumana Saleh; Hongyu Zhang; Brian Vukusic; Frank J S Lee; Fang Liu
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.